CoChat

The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis

Open access

The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.

Abstract

CXCL13 is a key B cell chemoattractant and marker of disease activity in patients with SLE; however, the mechanism of its induction has not been identified yet. Here, we have shown that the proteoglycan biglycan triggers CXCL13 expression via TLR2/4 in macrophages and dendritic cells. In vivo, levels of biglycan were markedly elevated in the plasma and kidneys of human SLE patients and lupus-prone (MRL/lpr) mice. Overexpression of soluble biglycan in MRL/lpr mice raised plasma and renal levels of CXCL13 and caused accumulation of B cells with an enhanced B1/B cell ratio in the kidney, worsening of organ damage, and albuminuria. Importantly, biglycan also triggered CXCL13 expression and B cell infiltration in the healthy kidney. Conversely, biglycan deficiency improved systemic and renal outcome in lupus-prone mice, with lower levels of autoantibodies, less enlargement of the spleen and lymph nodes, and reduction in renal damage and albuminuria. This correlated with a marked decline in circulating and renal CXCL13 and a reduction in the number of B cells in the kidney. Collectively, our results describe what we believe to be a novel mechanism for the regulation of CXCL13 by biglycan, a host-derived ligand for TLR2/4. Blocking biglycan-TLR2/4 interactions might be a promising strategy for the management of SLE and other B cell-mediated inflammatory disease entities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci42213

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 207

Metadata

Authors
Moreth, K., Brodbeck, R., Babelova, A., Gretz, N., Spieker, T., Zeng-Brouwers, J., Pfeilschifter, J., Young, M. F., Schaefer, R. M., & Schaefer, L.
Affiliations
  • Goethe University Frankfurt (DE)
  • Heidelberg University (DE)
  • University of Münster (DE)
  • National Institutes of Health (US)
Corresponding author
Schaefer, Liliana
Venue
Journal of Clinical Investigation
Published
2010-12-01
Volume
120
Issue
12
Pages
4251-4272
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1968712129
Cited by
207
References
70
Citations by year
2026: 5 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 20 · 2021: 22 · 2020: 13 · 2019: 15 · 2018: 8 · 2017: 12 · 2016: 8 · 2015: 18 · 2014: 15 · 2013: 14 · 2012: 18
FWCI
9.37
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (GRK1172, Project A7, SFB 815, project A5)
  • Else Kröner-Fresenius-Stiftung
  • Goethe-Universität Frankfurt am Main
  • National Institutes of Health (SFB 815)
  • National Institute of Dental and Craniofacial Research
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords
biglycan, CXCL13, systemic lupus erythematosus, lupus nephritis, TLR2/4 signaling, proteoglycans, macrophages, dendritic cells, MRL/lpr mice, albuminuria, autoantibodies
MeSH terms
Adolescent, Adult, Animals, B-Lymphocytes, Diabetic Nephropathies, Female, Graft Rejection, Humans, Kidney, Lupus Erythematosus, Systemic, Lupus Nephritis, Macrophages, Male, Mice, Inbred C57BL, Mice, Inbred NZB, T-Lymphocytes, Case-Control Studies, Cytokines, Mice, Knockout, Chemokines, Mice, Inbred MRL lpr, Toll-Like Receptor 2, Toll-Like Receptor 4, Mice, Chemokine CXCL13, Young Adult, Biglycan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.